ASLAN Pharmaceuticals to Co-Host KOL Panel Discussion on Changes in the Clinical Trial and

SAN MATEO, Calif. and SINGAPORE, Oct. 18, 2023 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused …